/PRNewswire/ The shareholders of Calliditas Therapeutics AB (publ), Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the annual.
Calliditas Therapeutics launches proposed global offering
Search jobs
Calliditas Therapeutics launches proposed global offering
January 26, 2021
Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX – CALTX; Nasdaq – CALT) will today launch a proposed public offering of American Depositary Shares ( ADSs ), in the United States for trading on The Nasdaq Global Select Market in the United States (the “U.S. Offering”) and a concurrent private placement of common shares to certain qualified investors in Europe and other countries outside of the United States (the Private Placement”, and together with the U.S. Offering, the “Global Offering”). The target size of the Global Offering is 4,500,000 common shares plus a potential 30-day over-allotment option of 15 percent of the common shares (including common shares in the form of ADSs) offered by Calliditas at the U.S. Offering price. The Global Offering is subject to market conditions and investor demand and
Calliditas Therapeutics launches proposed global offering
News provided by
Share this article
Calliditas Therapeutics AB (publ) ( Calliditas ) (Nasdaq OMX: CALTX) (Nasdaq: CALT)
will today launch a proposed public offering of American Depositary Shares ( ADSs ), in the United States for trading on The Nasdaq Global Select Market in the United States (the U.S. Offering ) and a concurrent private placement of common shares to certain qualified investors in Europe and other countries outside of the United States (the Private Placement , and together with the U.S. Offering, the Global Offering ). The target size of the Global Offering is 4,500,000 common shares plus a potential 30-day over-allotment option of 15 percent of the common shares (including common shares in the form of ADSs) offered by Calliditas at the U.S. Offering price. The Global Offering is subject to market conditions and investor demand and the number of ADSs (which represents two common shares) and common shar